| pubmed-article:17030908 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17030908 | lifeskim:mentions | umls-concept:C0024198 | lld:lifeskim |
| pubmed-article:17030908 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
| pubmed-article:17030908 | lifeskim:mentions | umls-concept:C0486805 | lld:lifeskim |
| pubmed-article:17030908 | pubmed:issue | Pt 11 | lld:pubmed |
| pubmed-article:17030908 | pubmed:dateCreated | 2006-10-10 | lld:pubmed |
| pubmed-article:17030908 | pubmed:abstractText | Recombinantly produced borrelial BBK32 protein fragments originating from Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii were evaluated as antigens in the serology of Lyme borreliosis (LB). In ELISA, a mid-portion hydrophilic fragment reacted with LB patient sera. Of the 23 patients with culture- or PCR-positive erythema migrans (EM), 43 % at diagnosis and 52 % at convalescence were positive for at least one Borrelia species-specific variant BBK32 fragment antigen. In parallel ELISAs with BBK32 whole proteins from the three borrelial subspecies as antigens, 17 % at diagnosis and 26 % at convalescence were positive. These results suggest that BBK32 protein fragments may improve the early IgG serology of LB compared to the BBK32 whole protein. | lld:pubmed |
| pubmed-article:17030908 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17030908 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17030908 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17030908 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17030908 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17030908 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17030908 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17030908 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17030908 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17030908 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17030908 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17030908 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17030908 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:17030908 | pubmed:issn | 0022-2615 | lld:pubmed |
| pubmed-article:17030908 | pubmed:author | pubmed-author:SeppäläIlkkaI | lld:pubmed |
| pubmed-article:17030908 | pubmed:author | pubmed-author:LahdennePekka... | lld:pubmed |
| pubmed-article:17030908 | pubmed:author | pubmed-author:SarvasHeikkiH | lld:pubmed |
| pubmed-article:17030908 | pubmed:author | pubmed-author:EholuotoMiiaM | lld:pubmed |
| pubmed-article:17030908 | pubmed:author | pubmed-author:SillanpääHeid... | lld:pubmed |
| pubmed-article:17030908 | pubmed:author | pubmed-author:KajanusRiikka... | lld:pubmed |
| pubmed-article:17030908 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17030908 | pubmed:volume | 55 | lld:pubmed |
| pubmed-article:17030908 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17030908 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17030908 | pubmed:pagination | 1499-504 | lld:pubmed |
| pubmed-article:17030908 | pubmed:meshHeading | pubmed-meshheading:17030908... | lld:pubmed |
| pubmed-article:17030908 | pubmed:meshHeading | pubmed-meshheading:17030908... | lld:pubmed |
| pubmed-article:17030908 | pubmed:meshHeading | pubmed-meshheading:17030908... | lld:pubmed |
| pubmed-article:17030908 | pubmed:meshHeading | pubmed-meshheading:17030908... | lld:pubmed |
| pubmed-article:17030908 | pubmed:meshHeading | pubmed-meshheading:17030908... | lld:pubmed |
| pubmed-article:17030908 | pubmed:meshHeading | pubmed-meshheading:17030908... | lld:pubmed |
| pubmed-article:17030908 | pubmed:meshHeading | pubmed-meshheading:17030908... | lld:pubmed |
| pubmed-article:17030908 | pubmed:meshHeading | pubmed-meshheading:17030908... | lld:pubmed |
| pubmed-article:17030908 | pubmed:meshHeading | pubmed-meshheading:17030908... | lld:pubmed |
| pubmed-article:17030908 | pubmed:meshHeading | pubmed-meshheading:17030908... | lld:pubmed |
| pubmed-article:17030908 | pubmed:meshHeading | pubmed-meshheading:17030908... | lld:pubmed |
| pubmed-article:17030908 | pubmed:meshHeading | pubmed-meshheading:17030908... | lld:pubmed |
| pubmed-article:17030908 | pubmed:meshHeading | pubmed-meshheading:17030908... | lld:pubmed |
| pubmed-article:17030908 | pubmed:meshHeading | pubmed-meshheading:17030908... | lld:pubmed |
| pubmed-article:17030908 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17030908 | pubmed:articleTitle | Antigenicity of borrelial protein BBK32 fragments in early Lyme borreliosis. | lld:pubmed |
| pubmed-article:17030908 | pubmed:affiliation | Hospital for Children and Adolescents, University of Helsinki, Stenbäckinkatu 11, FIN-00290 Helsinki, Finland. pekka.lahdenne@hus.fi | lld:pubmed |
| pubmed-article:17030908 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17030908 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17030908 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17030908 | lld:pubmed |
